Zycoxia P 60mg/325mg Tablet

The synergistic effect of these two active ingredients makes Zycoxia P suitable for managing acute and chronic musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative pain. It offers the advantage of potent anti-inflammatory action with a reduced risk of gastrointestinal side effects commonly associated with non-selective NSAIDs, due to the selective inhibition of COX-2 by Etoricoxib.

Paracetamol complements this by providing additional analgesic efficacy without significant anti-inflammatory activity. Zycoxia P should be used under medical supervision, with caution advised in patients with hepatic or renal impairment, cardiovascular disorders, or a history of gastrointestinal bleeding. The dosage and duration of therapy must be individualized based on clinical response and tolerability.